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Background: Chronic Rhinosinusitis (CRS) with (CRSwNP) and without nasal polyps (CRSsNP) are considered
heterogeneous entities of CRS. Studying inflammatory cells and their mediators in clearly defined subgroups (EP3OS
criteria) may lead to a better differentiation of CRS. The aim of present study was 1. to differentiate those subgroups
by means of the EP3OS criteria 2. to characterize the chemokine pattern in nasal tissue of CRSs/wNP and 3. to
evaluate the prevalence of IL-5 positivity and its impact on chemokine profile.
Method: There were 98 patients included in our prospective multicenter, case-control study; CRSwNP n=28,
CRSsNP n=45 and 25 controls undergoing septoplasty or conchotomy. Nasal tissue homogenates were analyzed by
ELISA for a range of chemokines: eotaxin, TARC, PARC, ENA-78, IP-10, MIP-1alpha, MCP-3 and for IL-5.
Result: In nasal tissue of CRSwNP patients we observed significantly elevated concentration of eotaxin, TARC, PARC,
ENA-78 and IP-10, as compared to controls. Patients with CRSsNP had only elevated concentration of TARC, as
compared to the control group. CRSwNP was characterized by increased concentration in tissue homogenates of
eotaxin, PARC, TARC and IL-5, but not of MIP-1alpha and MCP-3 compared to CRSsNP. Nasal tissue of CRSsNP
patients contained significantly more of ENA-78 and IP-10 than CRSwNP patients. IL-5 was detectable 34.1% of the
CRSsNP group and in 84.6% of CRSwNP samples. IL-5 positive CRSsNP samples had a significant higher chemokine
concentration for eotaxin, MIP-1alpha, PARC and TARC than IL-5- negative tissue. In IL-5 positive NP PARC was
increased significantly compared with IL-5 negative NP.
Conclusion: Defining the chemokine pattern may help to characterize specific CRS entities. Cluster analysis in
subgroups can lead to further understanding and classification of CRS. IL-5 appears to be a promising diagnostic
marker for further typing of CRS.
